Viral infections of the nervous system, 2002: Update on diagnosis and treatment

Archives of Neurology

Volumn 59, Issue 5, 2002, Pages 712-718

  Redington, John J ^a   Tyler, Kenneth L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE; ACICLOVIR; AMPRENAVIR; ANTIVIRUS AGENT; CIDOFOVIR; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FAMCICLOVIR; FOSCARNET; FOSCARNET SODIUM; GANCICLOVIR; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PLECONARIL; RIBAVIRIN; RITONAVIR; SAQUINAVIR; STAVUDINE; TENOFOVIR DISOPROXIL; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR; ZALCITABINE; ZIDOVUDINE;

BRAIN BIOPSY; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL TRIAL; CYTOMEGALOVIRUS INFECTION; DEMENTIA; EDITORIAL; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; MENINGITIS; NEUROLOGIC DISEASE; POLIOMYELITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; VARICELLA ZOSTER VIRUS; VIRUS ENCEPHALITIS; VIRUS INFECTION; WEST NILE FLAVIVIRUS;

EID: 0036091622     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.59.5.712     Document Type: Editorial

References (46)

1. Tables of antimicrobial agent pharmacology
2. AIDS dementia complex
3. Sustiva
4. Polymerase chain reaction in the diagnosis and management of central nervous system infections
5. Polymerase chain reaction as a diagnostic adjunct in herpesvirus infections of the nervous system
6. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF
7. Evaluation of the range of clinical presentations of herpes simplex encephalitis by using polymerase chain reaction assay of cerebrospinal fluid samples
8. The role of laboratory investigation in the diagnosis and management of patients with suspected herpes simplex encephalitis: A consensus report
9. Application of competitive PCR to cerebrospinal fluid samples from patients with herpes simplex encephalitis
10. Semiquantitative PCR analysis of Epstein-Barr virus DNA in clinical samples of patients with EBV-associated diseases
11. Human herpesvirus 6 is associated with focal encephalitis
12. Antiviral agents active against human herpesviruses HHV-6, HHV-7 and HHV-8
13. The outbreak of West Nile virus infection in the New York City area in 1999
14. Japanese encephalitis
15. Efficacy of single-dose SA 14-14-2 vaccine against Japanese encephalitis: A case control study
16. Nipah virus: A recent emergent deadly paramyxovirus
17. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia
18. Treatment of acute Nipah encephalitis with ribivarin
19. Treatment of potentially life-threatening enterovirus infections with pleconaril
20. "Endgame" issues for the global polio eradication initiative
21. Drugs for HIV infection
22. Alternative strategies for anti-HIV treatment
23. Inflammatory reactions in HIV-1 infected patients after initiation of highly active antiretroviral therapy
24. Acute HIV-1 disease as a mononucleosis-like illness: Is the diagnosis too restrictive?
25. Concentrations of human immunodeficiency virus type 1 (HIV-1) RNA in cerebrospinal fluid after antiretroviral treatment initiated during primary HIV-1 infection
26. HIV-associated neurological disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998
27. Antiretroviral treatment of central nervous system HIV-1 infection: A review
28. HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with abacavir
29. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
30. The CSF concentration/IC 50 ratio: A predictor of CNS antiretroviral efficacy
31. The effect of antiretroviral therapy in HTLV infection
32. Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection
33. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy
34. The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy
35. Clinical course and prognostic factors of AIDS-associated progressive multifocal leukoencephalopathy (PML) in patients treated with HAART (GESIDA 11/99)
36. Prospective pilot study of cidofovir for HIV-associated progressive multifocal leukoencephalopathy (PML)
37. Management of cytomegalovirus infection and disease after solid-organ transplantation
38. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients
39. Infections of the central nervous system in transplant receipts
40. Impact of highly active retroviral therapy on the onset of Mycobacterium avium complex infection and cytomegalovirus in patients with AIDS
41. Immune recovery vitritis and uveitis in AIDS: Clinical predictors, sequelae and treatment outcomes
42. Induction and maintenance therapy of cytomegalovirus central nervous system infection in HIV-infected patients
43. The sequelae of herpes zoster
44. Neurological complications of the reactivation of varicella-zoster virus
45. Varicella-zoster virus infections of the central nervous system: Clinical and pathologic correlates